Case Reports

Acral lentiginous melanoma with subsequent spontaneous vitiligo vulgaris: a case report and literature review

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 21 August 2024
Accepted: 22 January 2025
Published: 17 April 2025
584
Views
311
Downloads
4
HTML

Authors

Acral lentiginous melanoma (ALM) is an infrequent and often missed subtype of melanoma. Its association with spontaneous vitiligo vulgaris is an exceedingly rare condition. The current study presents a rare case of ALM with spontaneous vitiligo vulgaris after complete resection of the ALM. An 84-year-old male patient presented with multiple white skin lesions on the scalp, neck, trunk, and upper and lower limbs for a three-month duration. One year prior, a diagnosis of ALM was confirmed on histopathological examination with a pathological stage of T4bNxMx. The patient did not receive any treatment until the time of presentation, apart from the surgical removal of the primary tumor. No treatment was advised for the patient’s vitiligo vulgaris; only observation was recommended. Clinical diagnosis of vitiligo vulgaris was made based on the association with ALM. A review of the literature reveals that only a limited number of case reports have linked vitiligo to ALM, especially in cases where immunotherapeutic agents were not administered. Melanoma is a notably immunogenic malignancy, provoking both humoral and cellular immune responses directed against cytoplasmic and membrane antigens of melanocytes. It is suggested that normal melanocytes may function as neutral observers and become targets of immune responses directed against melanoma cells, leading to melanoma-associated vitiligo. It occurs more commonly as a consequence of immunologic-based therapeutic interventions or after metastatic melanoma; however, the occurrence of spontaneous vitiligo vulgaris several months following complete surgical removal of ALM is possible.

Downloads

Download data is not yet available.

Citations

1. Dabbas D, Neema S, Pathak N. Nivolumab induced vitiligo-like depigmentation in metastatic acral lentiginous melanoma. Pigment Int 2019;6:105-8.
2. Schadendorf D, van Akkooi AC, Berking C, et al. Melanoma. Lancet 2018;392:971-84.
3. Ahmed R, Sharif D, Jaf M, Amin DM. Effect of TNF-α− 308G/A (rs1800629) promoter polymorphism on the serum level of TNF-α among Iraqi patients with generalized vitiligo. Clin Cosmet Investig Dermatol 2020:825-35.
4. Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 2006;155:561-9.
5. Goydos JS, Shoen SL. Acral lentiginous melanoma. Melanoma 2016:321-9.
6. Ezzedine K, Lim HW, Suzuki TA, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012;25:E1-3.
7. Speeckaert R, van Geel N. Vitiligo: an update on pathophysiology and treatment options. Am J Clin Dermatol 2017;18:733-44.
8. Failla CM, Carbone ML, Fortes C, Pagnanelli G, D’Atri S. Melanoma and vitiligo: in good company. Int J Mol Sci 2019;20:5731.
9. Fouzia H, Amal K, Sarah B, et al. Melanoma Associated Leukoderma: Case Series and Literature Review. Am J Clin Med Res 2022;10:36-41.
10. Lommerts JE, Teulings HE, Ezzedine K, et al. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field. J Am Acad Dermatol 2016;75:1198-204.
11. Arpaia N, Cassano N, Vena GA. Regressing cutaneous malignant melanoma and vitiligo‐like depigmentation. Int J Dermatol 2006;45:952-6.
12. Markovic SN, Erickson LA, Rao RD, et al.; Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007;82:364-80.
13. Prasad S, Nassar M, Azzam AY, et al. CaReL Guidelines: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL). Barw Med J 2024;2:13-19.
14. Kim YJ, Lee JB, Kim SJ, et al. Amelanotic acral melanoma associated with KIT mutation and vitiligo. Ann Dermatol 2015;27:201-5.
15. Edmondson LA, Smith LV, Mallik A. Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report. J Oncol Pharm Pract 2017;23:629-34.
16. Spring IR, de Wet J, Jordaan HF, et al. Complete spontaneous regression of a metastatic acral melanoma with associated leukoderma. JAAD Case Rep 2017;3:524-8.
17. Ranaivo IM, Sendrasoa FA, Andrianarison M, et al. Vitiligo Associated with Melanoma in a Malagasy Woman. Case Rep Dermatol Med 2019;2019:7925785.
18. Deoghare S, Kumar A, Deora MS. An unusual case of acral lentiginous melanoma with leukoderma. Pigment Int 2021;8:52-4.
19. Zhao E. A Metastatic Melanoma Patient with Spontaneous Melanoma-Associated Vitiligo Survived for up to 7 Years and 5 Months: A Case Report. Ann Clin Med Case Rep 2022;8:1-5.
20. Quaglino P, Marenco F, Osella-Abate S, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol 2010;21:409-14.
21. Abdullah HO, Abdalla BA, Kakamad FH, et al. Predatory Publishing Lists: A Review on the Ongoing Battle Against Fraudulent Actions. Barw Med J 2024;2:26-30.
22. Jung HJ, Kweon SS, Lee JB, et al. A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. JAMA Dermatol 2013;149:1281-8.
23. Minagawa A, Omodaka T, Okuyama R. Melanomas and mechanical stress points on the plantar surface of the foot. New Engl J of Med 2016;374:2404-6.
24. Buljan M, Šitum M, Lugović L, Vučić M. Metastatic melanoma and vitiligo: a case report. Acta Dermatovener Cr 2006;14:100-3.
25. Daneshpazhooh M, Shokoohi A, Dadban A, Raafat J. The course of melanoma-associated vitiligo: report of a case. Melanoma Res 2006;16:371-3.
26. Wang JR, Yu KJ, Juan WH, Yang CH. Metastatic malignant melanoma associated with vitiligo‐like depigmentation. Clin Exp Dermatol 2009;34:209-11.
27. Nakamura Y, Fujisawa Y. Diagnosis and management of acral lentiginous melanoma. Curr Treat Options Oncol 2018;19:1-1.

How to Cite



1.
Ahmed RS, Ali RR, Hiwa DS, Ghafour AK, Siddiq SO, Asaad SK, et al. Acral lentiginous melanoma with subsequent spontaneous vitiligo vulgaris: a case report and literature review. Dermatol Reports [Internet]. 2025 Apr. 17 [cited 2026 May 4];17(4). Available from: https://journals.pagepress.net/dr/article/view/10125